(Q32068104)

English

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

based on heuristic

inferred from title

Jonathan Emberson

3

object named as

J Emberson

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

author name string

I R Reid

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

W Hague

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

J Baker

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

D Hunt

6

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

S MacMahon

7

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

N Sharpe

8

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

A Tonkin

5

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

357

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

9255

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

509-512

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral statins and increased bone-mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors and the risk of fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Age- and Gender-Specific Rate of Fractures in Australia: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of hyperinsulinemia in atherosclerotic coronary arterial disease: studies of semi-quantitative coronary angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904042-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)04042-3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32068104&oldid=2063424644"